Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

13.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.5K
Mismatch Repair01:20

Mismatch Repair

5.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.8K
Mismatch Repair01:36

Mismatch Repair

42.7K
Overview
42.7K
Mutations01:39

Mutations

91.3K
Overview
91.3K
Translation01:31

Translation

16.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
16.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Effectiveness of Vaccine for the Prevention of Herpes Zoster in Kidney Transplant Recipients in Thailand.

Value in health regional issues·2026
Same author

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026
Same author

Mechanistic insights into emerging therapeutic platforms: The 72<sup>nd</sup> annual Montagna Symposium on the Biology of Skin.

The Journal of investigative dermatology·2026
Same author

Thin and in situ melanoma: an update for the dermatologist.

Anais brasileiros de dermatologia·2026
Same author

Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma education.

Frontiers in medicine·2026
Same author

A Rare T-Cell Factor 4 Lineage-negative Epithelial Stem Cell Supports Wound Repair and APC-deletion-induced Colon Tumorigenesis.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Nov 18, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.0K

Clinical challenges in interpreting multiple pathogenic mutations in single patients.

Christa Slaught1, Elizabeth G Berry2, Lindsay Bacik3

  • 1Department of Dermatology, Oregon Health & Science University, 3303 SW Bond Ave, Suite 16D, Portland, OR, 97239, USA.

Hereditary Cancer in Clinical Practice
|February 5, 2021
PubMed
Summary

Multi-gene panel testing for cancer risk reveals complex genetic interactions. Understanding these interactions is crucial for personalized patient counseling and management strategies.

Keywords:
BAP-1Compound heterozygosityGeneticsMSH6MelanomaRECQL4

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.0K

Related Experiment Videos

Last Updated: Nov 18, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.0K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.0K

Area of Science:

  • Genetics
  • Oncology
  • Clinical Practice

Background:

  • Multi-gene panel testing is common for cancer risk assessment.
  • Clinical utility of these panels, especially with multiple variants, is not fully established.
  • Interactions between multiple pathogenic variants and environmental factors complicate cancer risk.

Purpose of the Study:

  • To highlight challenges in counseling patients with multiple pathogenic variants found via multi-gene panel testing.
  • To illustrate difficulties in determining appropriate interventions for such cases.

Main Methods:

  • Presentation of two cases (individual and family) with multiple pathogenic mutations identified by multi-gene panel testing.

Main Results:

  • Identified challenges in clinical decision-making for patients with multiple incidental mutations.
  • Demonstrated the complexity of managing patients without classic histories for identified predispositions.

Conclusions:

  • Further research is needed to understand inherited disease susceptibility and cancer predisposition syndromes.
  • Development of precise, patient-specific counseling and surveillance strategies is essential.
  • Clinical decision-making often occurs without full understanding of gene-gene interactions, relying on clinical concordance and history.